Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Necrotic tissue proteins, fibrin, and fibrinogen constitute the non-viable biological debris found in chronic wounds, such as pressure sores and diabetic ulcers, often manifesting as slough or eschar. Fibrin is an insoluble protein polymer derived from fibrinogen that forms a scaffold for blood clotting and early wound repair (StatPearls, 2023). However, its persistence in chronic ulcers can form fibrin cuffs that hinder oxygen diffusion and nutrient exchange, thereby stalling the healing process (PubMed, PMC1192448). Necrotic proteins result from cell death and tissue degradation, creating a pro-inflammatory environment that promotes bacterial colonization and biofilm formation (NIH, 2022). Therapeutic strategies target these components through enzymatic debridement, utilizing exogenous proteases to selectively digest the proteinaceous debris (Wounds, 2014). Agents such as collagenase or bromelain hydrolyze these denatured proteins without harming the underlying viable tissue. By removing these physical and biochemical barriers, these drugs facilitate the transition of the wound from a chronic inflammatory state to the proliferative phase of healing. This clearance also improves the efficacy of other topical treatments and reduces the risk of infection.
Enzymatic debridement through the proteolytic degradation of denatured proteins and fibrin
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Necrotic tissue proteins and fibrin.